Afatinib (BIBW 2992) in Advanced Non-Small Cell Lung Cancer Patients With EGFR Mutation
Clinical trial NCT01953913 · COMPLETED
Trial details
- NCT number
- NCT01953913
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-30
- Primary completion
- 2018-07-06
- Enrollment
- 542
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.